Literature DB >> 9068131

John H. Gibbon. The first 20 years of the heart-lung machine.

A A Fou.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9068131      PMCID： PMC325389     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  5 in total

1.  A double perfusion-pump.

Authors:  H H Dale; E H Schuster
Journal:  J Physiol       Date:  1928-02-10       Impact factor: 5.182

2.  Prevention of street virus infection by vaccine.

Authors:  C TENBROECK
Journal:  Proc Soc Exp Biol Med       Date:  1950-11

3.  The development of the heart-lung apparatus.

Authors:  J H Gibbon
Journal:  Am J Surg       Date:  1978-05       Impact factor: 2.565

4.  The development of the heart-lung apparatus.

Authors:  J H Gibbon
Journal:  Rev Surg       Date:  1970 Jul-Aug

5.  The development of heart lung machines.

Authors:  B J Miller
Journal:  Surg Gynecol Obstet       Date:  1982-03
  5 in total
  4 in total

1.  A Tribute to Frank F Alibritten, Jr. Origin of the left ventricular vent during the early years of open-heart surgery with the Gibbon heart-lung machine.

Authors:  K D Hedlund
Journal:  Tex Heart Inst J       Date:  2001

2.  Ventricular assist devices in pediatrics.

Authors:  A Fuchs; H Netz
Journal:  Images Paediatr Cardiol       Date:  2001-10

3.  Advanced mechanical circulatory support for post-cardiotomy cardiogenic shock: a 20-year outcome analysis in a non-transplant unit.

Authors:  Maziar Khorsandi; Kasra Shaikhrezai; Sai Prasad; Renzo Pessotto; William Walker; Geoffrey Berg; Vipin Zamvar
Journal:  J Cardiothorac Surg       Date:  2016-02-18       Impact factor: 1.637

Review 4.  Extra-corporeal membrane oxygenation for refractory cardiogenic shock after adult cardiac surgery: a systematic review and meta-analysis.

Authors:  Maziar Khorsandi; Scott Dougherty; Omar Bouamra; Vasudev Pai; Philip Curry; Steven Tsui; Stephen Clark; Stephen Westaby; Nawwar Al-Attar; Vipin Zamvar
Journal:  J Cardiothorac Surg       Date:  2017-07-17       Impact factor: 1.637
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.